Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of Adalimumab Efficacy in Ankylosing Spondylitis
NCT02492217Phase 4Completed
- Sponsor
- NOVA University Lisbon
- Start
- May 2015
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in ankylosing spondylitis (AS), sponsored by NOVA University Lisbon. Started May 2015; status: completed.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02492217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492217.